• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BOD
Click for more information
0.00% 2.4¢

BOD SCIENCE LIMITED

Market Cap $4.256M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Bod Science Limited is an Australia-based cannabis focused drug development and product... Bod Science Limited is an Australia-based cannabis focused drug development and product innovation company. The Company is focused on progressing research and development with a defined clinical trial pathway to commercialize and deliver products for consumer and medical markets. The principal activities of the Company are the development and distribution of therapeutic medicinal cannabis products based on good manufacturing practice (GMP) certified cannabis extracts for medical markets in Australia and the United Kingdom, as well as the development of cannabidiol (CBD) and hemp products for consumer markets in Australia, the United Kingdom, Europe, and United States. The Company’s segments include medical, over the counter cannabidiol/Hemp (OTC CBD/Hemp) and OTC Herbals. The Company offers products for health and wellness, joint/muscle pain and general wellbeing, and stress/anxiety and sleep. The Company also owns the Aqua Phase delivery technology.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BOD
Ann: Change of Director's Interest Notices 		07/08/24 0 212
07/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  212 
BOD
Ann: Notification of cessation of securities - BOD 		07/08/24 0 130
07/08/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  130 
BOD
Ann: Quarterly Activities/Appendix 4C Cash Flow Report 		22/07/24 0 297
22/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 
BOD
Ann: Appendix 4D and Half Year Account 		18/07/24 2 913
18/07/24 Last post  Keith2 Comments Created with Sketch.  2  Views Created with Sketch.  913 
BOD
Ann: Notice to Shareholders 		16/07/24 0 303
16/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  303 
BOD
Ann: Long Term Suspended Entities 		10/07/24 0 344
10/07/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  344 
BOD
News: BOD Bod Science Announces Further Delay In Lodgement Of Appendix 4D & Half Year Report 		27/06/24 2 1.2K
27/06/24 Last post  kipper57 Comments Created with Sketch.  2  Views Created with Sketch.  1.2K 
BOD
Ann: Further delay in lodgement of Appendix 4D & Half Year Report 		17/06/24 0 297
17/06/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notices
07 Aug 15:55
 
Notification of cessation of securities - BOD
07 Aug 15:40
 
Quarterly Activities/Appendix 4C Cash Flow Report
22 Jul 12:02
 
Appendix 4D and Half Year Account
18 Jul 16:17
 
Notice to Shareholders
16 Jul 12:58
 
Long Term Suspended Entities
10 Jul 16:15
 
View More arrow Created with Sketch.

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.

(20min delay)
Last
2.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $4.256M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
BOD (ASX) Chart

Top Stories

Reporting wrap: Inghams, Accent, Mayne Pharma

Inghams Group Ltd, Accent Group Ltd and Mayne Pharma Group Ltd all reported final year results for the 2024 fiscal year.
Noronex kicks off EM survey at Humpback, Namibia – part of South32's earn-in deal to access Kalahari Copper Belt Noronex Limited (ASX:NRX) has kicked off a gravity EM survey at the Damara project in Namibia – part of its earn-in deal with South32.
Week 34 Wrap: HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back This week’s biggest story (in my view) for the Australian economy actually started late last week. Quietly, CBA cut its term deposit interest rates, prompting ANZ and NAB to do the same on Monday of this week.
IPH raises $100M to buy up Canadian IP firm Bereskin & Parr IPH Ltd has raised $100 million in an institutional placement to support the acquisition, while also launching a share purchase plan.
The business of sport: Warren Tredrea's take on this week's news Former Port Adelaide AFL star – turned media personality – Warren Tredrea and co-host Jack Hudson explore money in sport.

Featured News

SBW Shekel Brainweigh provides key business update ahead of final 2024 quarter
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.